http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040025224-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea1fff38e27d2aa34504ab65f60e7631
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2002-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2ac39b7744d89c7d54fc6ba07efdbf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a98755d4d5d3355af4f2507a771011d
publicationDate 2004-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20040025224-A
titleOfInvention 2-(2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)acetaldehyde and preparation process of the same
abstract The present invention is a novel compound 2- (2-methyl-4-oxo-6,7,8,9-tetrahydro-4H of formula 8, which is a novel compound that can be usefully used as a starting material of risperidone widely used as a psychotherapy agent. 2- (2-methyl-4-oxo to prepare a compound of formula 8 by oxidizing a pyrido [1,2-a] pyrimidin-3-yl) acetaldehyde with a compound of formula 9 in the presence of an oxidant Provided is a method for preparing -6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-3-yl) acetaldehyde or acid addition salts thereof.n n n <Formula 8>n n n n n n n n <Formula 9>n n n n n n n n In Formula 9, Z is a halide or OH group selected from chloro, bromo, iodo.
priorityDate 2002-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03074522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0196132-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0368388-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000005226-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0185731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20020081146-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0453042-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450514992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453598505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457382234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2763079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421283745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416178040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11413127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID849421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID354785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421582457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450313723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22462060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415951404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10214467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424325787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457706951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671

Total number of triples: 51.